PH23840A - The use of alpha-21 selective adrenergic receptor agonists in memory enhancement - Google Patents
The use of alpha-21 selective adrenergic receptor agonists in memory enhancementInfo
- Publication number
- PH23840A PH23840A PH35973A PH35973A PH23840A PH 23840 A PH23840 A PH 23840A PH 35973 A PH35973 A PH 35973A PH 35973 A PH35973 A PH 35973A PH 23840 A PH23840 A PH 23840A
- Authority
- PH
- Philippines
- Prior art keywords
- alpha
- receptor agonists
- adrenergic receptor
- memory enhancement
- selective adrenergic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/928,442 US4847300A (en) | 1986-11-07 | 1986-11-07 | Use of alpha-2I selective adrenergic receptor agonists in memory enhancement |
Publications (1)
Publication Number | Publication Date |
---|---|
PH23840A true PH23840A (en) | 1989-11-23 |
Family
ID=25456234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH35973A PH23840A (en) | 1986-11-07 | 1987-10-22 | The use of alpha-21 selective adrenergic receptor agonists in memory enhancement |
Country Status (12)
Country | Link |
---|---|
US (1) | US4847300A (de) |
EP (1) | EP0268912A3 (de) |
JP (1) | JPS63183524A (de) |
KR (1) | KR880005926A (de) |
AU (1) | AU601771B2 (de) |
CA (1) | CA1307741C (de) |
DK (1) | DK546287A (de) |
IE (1) | IE872994L (de) |
IL (1) | IL84223A0 (de) |
NZ (1) | NZ222464A (de) |
PH (1) | PH23840A (de) |
PT (1) | PT86059B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5744476A (en) * | 1994-06-27 | 1998-04-28 | Interneuron Pharmaceuticals, Inc. | Dopamine D1 agonists for the treatment of dementia |
US5854290A (en) * | 1995-09-21 | 1998-12-29 | Amy F. T. Arnsten | Use of guanfacine in the treatment of behavioral disorders |
EP1893576A4 (de) * | 2005-05-27 | 2010-03-17 | Univ Kingston | Behandlung von proteinfaltungsstörungen |
US20090076156A1 (en) * | 2005-07-18 | 2009-03-19 | Masud Husain | Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders |
FR2893844B1 (fr) * | 2005-11-28 | 2008-02-01 | Centre Nat Rech Scient | Utilisation du guanabenz et de ses derives pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules |
US20120041068A1 (en) * | 2010-08-11 | 2012-02-16 | Aptapharma, Inc. | Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE893276A (fr) * | 1981-06-01 | 1982-11-24 | Sandoz Sa | Nouvelle application therapeutique d'un derive de l'acetamide |
CH649918A5 (de) * | 1981-07-09 | 1985-06-28 | Sandoz Ag | Verwendung von n-amidino-2-phenylacetamiden als wirkstoff zur herstellung von pharmazeutischen zubereitungen gegen schizophrenie. |
-
1986
- 1986-11-07 US US06/928,442 patent/US4847300A/en not_active Expired - Lifetime
-
1987
- 1987-10-14 AU AU79770/87A patent/AU601771B2/en not_active Ceased
- 1987-10-19 DK DK546287A patent/DK546287A/da not_active Application Discontinuation
- 1987-10-20 IL IL84223A patent/IL84223A0/xx unknown
- 1987-10-22 PH PH35973A patent/PH23840A/en unknown
- 1987-10-29 JP JP62271984A patent/JPS63183524A/ja active Pending
- 1987-11-02 PT PT86059A patent/PT86059B/pt not_active IP Right Cessation
- 1987-11-05 NZ NZ222464A patent/NZ222464A/xx unknown
- 1987-11-06 IE IE872994A patent/IE872994L/xx unknown
- 1987-11-06 CA CA000551279A patent/CA1307741C/en not_active Expired - Lifetime
- 1987-11-07 EP EP87116470A patent/EP0268912A3/de not_active Withdrawn
- 1987-11-07 KR KR870012549A patent/KR880005926A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU7977087A (en) | 1988-05-12 |
DK546287D0 (da) | 1987-10-19 |
IE872994L (en) | 1988-05-07 |
IL84223A0 (en) | 1988-03-31 |
US4847300A (en) | 1989-07-11 |
NZ222464A (en) | 1990-08-28 |
CA1307741C (en) | 1992-09-22 |
PT86059A (en) | 1987-12-01 |
AU601771B2 (en) | 1990-09-20 |
KR880005926A (ko) | 1988-07-21 |
DK546287A (da) | 1988-05-08 |
EP0268912A3 (de) | 1990-02-28 |
EP0268912A2 (de) | 1988-06-01 |
JPS63183524A (ja) | 1988-07-28 |
PT86059B (pt) | 1990-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2163747B (en) | Benzimidazole derivatives, and antiulcer agents containing the same | |
EP0246767A3 (en) | Semiconductor memories | |
YU44720B (en) | Small memory for use in central processing unit | |
KR960003228B1 (en) | Semiconductor memory | |
GB2190771B (en) | Memory device | |
EP0273639A3 (en) | Semiconductor memory | |
DE3462279D1 (en) | Well probe anchoring device with expansible pivoting arms | |
GB8708794D0 (en) | Dissolution cell | |
EP0238228A3 (en) | Semiconductor memory | |
EP0264929A3 (en) | Semiconductor memory device with improved bit line arrangement | |
GB8704694D0 (en) | Bit line equalization in memory | |
EP0265108A3 (en) | Cache storage priority | |
PH23840A (en) | The use of alpha-21 selective adrenergic receptor agonists in memory enhancement | |
EP0260837A3 (en) | Microprocessor with selective cache memory | |
GB8827224D0 (en) | Memories | |
EP0263318A3 (en) | Semiconductor memory | |
GB2176357B (en) | Improvements in semiconductor memories | |
EP0230385A3 (en) | Semiconductor memory | |
DE3474304D1 (en) | Bismorpholines, process for their preparation and their use as anti-hydrolysis agents | |
GB2196049B (en) | Water storage | |
GB2137382B (en) | Computer memories | |
HUT35839A (en) | Arms used in sword-play | |
GB8703350D0 (en) | Testing memory | |
GB8624776D0 (en) | Sphere/spheroid holder | |
EP0254886A3 (en) | Serially-accessed type memory device |